Cell And Gene Therapy Manufacturing
-
A Robust, Future-Ready Solution That Adapts To Your Needs
5/22/2025
Explore a future-ready solution that features advanced automation, intuitive design, and scalable solutions to streamline your bioprocessing workflows and prepare your operations for future growth.
-
A Collaboration With Fresenius Kabi BioPharm
5/19/2025
Explore how biosimilar development is advancing through collaboration, innovative cell culture strategies, and the use of advanced media to meet biomanufacturing goals.
-
Uninstalling CTS Dynacellect Bead Removal Kit
6/9/2025
A detailed walkthrough on how to uninstall the Gibco CTS DynaCellect Bead Removal Kit when the bead removal protocol or the Gibco CTS DynaCellect magnetic separation system is completed.
-
Autoimmune Disease Research's Impact On The Development Of Cell Therapies For Oncology
5/6/2024
Recently, many cell therapy companies have been pivoting to autoimmune diseases. Expert panelists discuss whether they think there are any learnings or potential headwinds these pivots could provide to cell therapies for oncology.
-
Dr. Peter Marks Talks a Standardized Playbook for Gene Therapy Manufacturing
1/30/2024
In this segment, Dr. Peter Marks shares developments in CMC for advanced therapies in the near future.
-
Validation Of A qPCR Assay For Host Cell DNA Quantitation
6/9/2025
Here, we share the development and validation of a new, highly sensitive and accurate integrated solution for detection and quantitation of host cell DNA to help meet regulatory requirements.
-
Scaling Viral Vectors
11/13/2023
Industry experts cover the high operational costs associated with viral vectors, along with the challenge presented by their shot shelf life and scalability.
-
Why Clinical Requirements Change: Dr. Peter Marks on Pre-IND Meeting Pathways
1/30/2024
Learn how clinical requirements change after the FDA and a company agree on a pathway during a pre-IND meeting and how the company might recover as a result.
-
Major Advancements In mRNA
1/29/2024
Experts on this Cell & Gene live event discuss the major scientific biological advances in understanding the potential for mRNA-based immunotherapies vaccines for cancer over the last 2 years.
-
Maximize Quality Assurance Through Rapid Sterility Testing
9/10/2024
This webinar explores mitigating the risk of product loss, and production delays, as well as the critical role rapid sterility testing plays in ensuring the quality and safety of cell therapy products.